A histamine H3 receptor antagonist
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Thioperamide

Item No. 45928

Technical Information
Formal Name
N-cyclohexyl-4-(1H-imidazol-5-yl)-1-piperidinecarbothioamide
CAS Number
106243-16-7
Synonyms
  • MR12842
Molecular Formula
C15H24N4S
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
S=C(NC1CCCCC1)N(CC2)CCC2C3=CN=CN3
InChi Code
InChI=1S/C15H24N4S/c20-15(18-13-4-2-1-3-5-13)19-8-6-12(7-9-19)14-10-16-11-17-14/h10-13H,1-9H2,(H,16,17)(H,18,20)
InChi Key
QKDDJDBFONZGBW-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Thioperamide is a histamine H3 receptor antagonist (Ki = 4.3 nM).1 It is selective for the histamine H3 receptor over histamine H1 and H2 receptors (Kis = >10,000 nM for both) and a panel of 36 other receptors and ion channels. Thioperamide inhibits amygdaloid-kindled seizures (ED50 = 3.43 mg/kg) and reverses antinociception induced by the histamine H3 receptor agonist immepip (Item No. 29518) in rats.2,3 Thioperamide increases the time spent awake and decreases the time spent in deep slow wave sleep in rats.4 It decreases cognitive impairments in the APP/PS1 transgenic mouse model of Alzheimer’s disease.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Leurs, R., Tulo, M.T., Menge, W.M., et alEvaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br. J. Pharmacol. 116(4), 2315-2321 (1995).

    2. Harada, C., Fujii, Y., Hirai, T., et alInhibitory effect of iodophenpropit, a selective histamine H3 antagonist, on amygdaloid kindled seizures. Brain Res. Bull. 63(2), 143-146 (2004).

    3. Cannon, K.E., Leurs, R., and Hough, L.B. Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively. Pharmacol. Biochem. Behav. 88(1), 122-129 (2007).

    4. Bonaventure, P., Letavic, M., Dugovic, C., et alHistamine H3 receptor antagonists: From target identification to drug leads. Biochem. Pharmacol. 73(8), 1084-1096 (2007).

    5. Wang, J., Liu, B., Xu, Y., et alThioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer’s disease via inhibiting gliosis. Exp. Neurol. 347, 113870 (2022).